Pfiz­er sets Paxlovid price at $1,390 for five-day course

Pfiz­er will charge $1,390 for a five-day course of Paxlovid on the com­mer­cial mar­ket, in­creas­ing the price from the pan­dem­ic-era rate it had been giv­ing to the US gov­ern­ment.

The drug­mak­er last week an­nounced the end of a pro­gram where US health au­thor­i­ties bought and were re­spon­si­ble for dis­trib­ut­ing the Paxlovid dos­es at a price of $530 per course. Many of those pills, cleared un­der emer­gency use au­tho­riza­tion, will be re­turned to the drug­mak­er. Be­cause of that, and be­cause of de­clin­ing de­mand for Covid prod­ucts over­all, Pfiz­er is em­bark­ing on a $3.5 bil­lion cost-cut­ting pro­gram this year and next.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.